328 related articles for article (PubMed ID: 9972795)
1. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.
Schlicker A; Peschke P; Bürkle A; Hahn EW; Kim JH
Int J Radiat Biol; 1999 Jan; 75(1):91-100. PubMed ID: 9972795
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis.
Noël G; Godon C; Fernet M; Giocanti N; Mégnin-Chanet F; Favaudon V
Mol Cancer Ther; 2006 Mar; 5(3):564-74. PubMed ID: 16546970
[TBL] [Abstract][Full Text] [Related]
3. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ
Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
Bryant HE; Helleday T
Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
[TBL] [Abstract][Full Text] [Related]
5. Benzamide and 4-amino 1,8 naphthalimide treatment inhibit telomerase activity by down-regulating the expression of telomerase associated protein and inhibiting the poly(ADP-ribosyl)ation of telomerase reverse transcriptase in cultured cells.
Ghosh U; Bhattacharyya NP
FEBS J; 2005 Aug; 272(16):4237-48. PubMed ID: 16098204
[TBL] [Abstract][Full Text] [Related]
6. PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility.
Godon C; Cordelières FP; Biard D; Giocanti N; Mégnin-Chanet F; Hall J; Favaudon V
Nucleic Acids Res; 2008 Aug; 36(13):4454-64. PubMed ID: 18603595
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells.
Muñoz-Gámez JA; Quiles-Pérez R; Ruiz-Extremera A; Martín-Álvarez AB; Sanjuan-Nuñez L; Carazo A; León J; Oliver FJ; Salmerón J
Cancer Lett; 2011 Feb; 301(1):47-56. PubMed ID: 21093979
[TBL] [Abstract][Full Text] [Related]
8. Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.
Horton JK; Stefanick DF; Gassman NR; Williams JG; Gabel SA; Cuneo MJ; Prasad R; Kedar PS; Derose EF; Hou EW; London RE; Wilson SH
DNA Repair (Amst); 2013 Sep; 12(9):774-85. PubMed ID: 23871146
[TBL] [Abstract][Full Text] [Related]
9. [Effect and Mechanism of Radiosensitization of Poly (ADP-Ribose) Polymerase Inhibitor n Lewis Cells and Xenografts].
Wang W; Duan B; Zeng L
Zhongguo Fei Ai Za Zhi; 2016 Jan; 19(1):16-23. PubMed ID: 26805733
[TBL] [Abstract][Full Text] [Related]
10. Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.
Heacock ML; Stefanick DF; Horton JK; Wilson SH
DNA Repair (Amst); 2010 Aug; 9(8):929-36. PubMed ID: 20573551
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation.
Hirai T; Shirai H; Fujimori H; Okayasu R; Sasai K; Masutani M
Cancer Sci; 2012 Jun; 103(6):1045-50. PubMed ID: 22404155
[TBL] [Abstract][Full Text] [Related]
12. Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.
Calabrese CR; Almassy R; Barton S; Batey MA; Calvert AH; Canan-Koch S; Durkacz BW; Hostomsky Z; Kumpf RA; Kyle S; Li J; Maegley K; Newell DR; Notarianni E; Stratford IJ; Skalitzky D; Thomas HD; Wang LZ; Webber SE; Williams KJ; Curtin NJ
J Natl Cancer Inst; 2004 Jan; 96(1):56-67. PubMed ID: 14709739
[TBL] [Abstract][Full Text] [Related]
13. Predicting enhanced cell killing through PARP inhibition.
Horton JK; Wilson SH
Mol Cancer Res; 2013 Jan; 11(1):13-8. PubMed ID: 23193155
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
Parsons JL; Dianova II; Allinson SL; Dianov GL
FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase.
Brock WA; Milas L; Bergh S; Lo R; Szabó C; Mason KA
Cancer Lett; 2004 Mar; 205(2):155-60. PubMed ID: 15036647
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1.
Veuger SJ; Curtin NJ; Richardson CJ; Smith GC; Durkacz BW
Cancer Res; 2003 Sep; 63(18):6008-15. PubMed ID: 14522929
[TBL] [Abstract][Full Text] [Related]
17. PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation.
Chalmers A; Johnston P; Woodcock M; Joiner M; Marples B
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):410-9. PubMed ID: 14751510
[TBL] [Abstract][Full Text] [Related]
18. Effect of poly(ADP-ribosyl)ation inhibitors on the genotoxic effects of the boron neutron capture reaction.
Oliveira NG; Castro M; Rodrigues AS; Gonçalves IC; Martins C; Toscano Rico JM; Rueff J
Mutat Res; 2005 May; 583(1):36-48. PubMed ID: 15866464
[TBL] [Abstract][Full Text] [Related]
19. Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair.
Löser DA; Shibata A; Shibata AK; Woodbine LJ; Jeggo PA; Chalmers AJ
Mol Cancer Ther; 2010 Jun; 9(6):1775-87. PubMed ID: 20530711
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure.
Horton JK; Stefanick DF; Naron JM; Kedar PS; Wilson SH
J Biol Chem; 2005 Apr; 280(16):15773-85. PubMed ID: 15701627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
